Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
INTERACT trial in locally advanced rectal cancer
2005-005475-14Phase 3Completed
- Sponsor
- Policlinico Gemelli
- Start
- Jan 2006
- Modality
- DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of oxaliplatin in rectal cancer and rectal adenocarcinoma (2 arms), sponsored by Policlinico Gemelli. Primary endpoint: T pathological major downstaging. Started Jan 2006; status: completed.
02
Drugs
oxaliplatin
03
Conditions
rectal cancerrectal adenocarcinoma
Beyond the preview
Go deeper on 2005-005475-14.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-005475-14.